awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q45893661-26B074DB-EBB4-4E3C-AF56-ADC526E0515E
Q45893661-26B074DB-EBB4-4E3C-AF56-ADC526E0515E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q45893661-26B074DB-EBB4-4E3C-AF56-ADC526E0515E
Cost-Effectiveness of Golimumab in Ankylosing Spondylitis from the UK Payer Perspective.
P2860
Q45893661-26B074DB-EBB4-4E3C-AF56-ADC526E0515E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q45893661-26B074DB-EBB4-4E3C-AF56-ADC526E0515E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2de976a1e7eec67210e50a353f5e436c1da37daf
P2860
Adalimumab significantly reduces inflammation and serum DKK-1 level but increases fatty deposition in lumbar spine in active ankylosing spondylitis.